a a Trends & Opportunities
in Early Growth Markets
    MicroRNA Analysis
 
Life Science
Dashboard™
 
  2008 Dashboards:
    Gene Expression Profiling
    Gene Silencing
    Nucleic Acid Separation
  2007 Dashboards:
  Nucleic Acid Purification
    Nucleic Acid Amplification
    Transfection
    Cell Culture
    Gene Silencing
    Gene Expression Profiling
 
  Life Science Marketing
Series
  Subscribe
  Privacy Policy
Publications : 2007 Transfection Dashboard
Series 1
Catalog number: 0701TFN
Publication date: January 2007
Company-wide electronic copy: $3,000

Please enquire about single-user* electronic copy pricing
* single-user pricing is intended for small companies, of 40 or less employees, to access The Life Science Dashboard. Please order these copies directly with Percepta Associates.
 

Table of Contents

Figures and Tables
Executive Summary
Key Findings and Implications
Transfection Dashboard
Transfection Market Opportunity Matrix
Survey Methodology
Survey Invitation Text
Respondent Demographics
Frequency of Performance of Molecular Biology Techniques
Frequency of Performance of Transfection of Mammalian Cells or Cell Lines
Reaction Throughput and Market Growth Rates
Respondent’s Stated Price Per Reaction
Total Market Size, Market Segment Sizes and Total Market Growth Rate
Market Shares for Products for Chemically-Mediated Transfection of Mammalian Cells or Cell Lines
Market Shares for Products for Lipid-Mediated Transfection of Mammalian Cells or Cell Lines
Market Shares for Products for Instrument-Mediated Transfection of Mammalian Cells or Cell Lines
Customer Satisfaction And Interest In Switching Suppliers
Product Features That Influence Purchasing Decisions
Primary and Secondary Downstream Applications
Desired Changes to Transfection Products
Survey Questionnaire

Figures and Tables
Figure 1: Respondent’s Place of Employment
Figure 2: Respondent’s Country/Region
Figure 3: Respondent’s Job Title
Figure 4: Respondent’s Areas of Expertise/Specialization
Figure 5: Number of Employees in Respondent’s Laboratories
Figure 6: Percentage of Respondents Performing Various Techniques at Least
                 a Few Times per Year
Figure 7: Percentage of Respondents Transfecting Mammalian Cells or Cell
                 Lines
Figure 8: Percentage of Respondents Performing Transfection of Mammalian
                 Cells or Cell Lines at Least a Few Times Per Year
Figure 9: Percentage of Respondents Performing Chemically-Mediated
                 Transfection of Mammalian Cells or Cell Lines
Figure 10: Percentage of Respondents Performing Lipid-Mediated Transfection
                    of Mammalian Cells or Cell Lines
Figure 11: Percentage of Respondents Performing Instrument-Mediated
                    Transfection of Mammalian Cells or Cell Lines
Figure 12: Respondent’s Primary Supplier for Chemically-Mediated Transfection
                    of Mammalian Cells or Cell Lines
Figure 13: Respondent’s Primary Supplier for Chemically-Mediated Transfection
                    of Mammalian Cells or Cell Lines by Region
Figure 14: Respondent’s Primary Supplier for Chemically-Mediated Transfection
                    of Mammalian Cells or Cell Lines by Organization Type
Figure 15: Respondent’s Primary Supplier for Lipid-Mediated Transfection of
                    Mammalian Cells or Cell Lines
Figure 16: Respondent’s Primary Supplier for Lipid-Mediated Transfection of
                    Mammalian Cells or Cell Lines by Region
Figure 17: Respondent’s Primary Supplier for Lipid-Mediated Transfection of
                    Mammalian Cells or Cell Lines by Organization Type
Figure 18: Respondent’s Primary Supplier for Instrument-Mediated Transfection
                    of Mammalian Cells or Cell Lines
Figure 19: Respondent’s Primary Supplier for Instrument-Mediated Transfection
                    of Mammalian Cells or Cell Lines by Region
Figure 20: Respondent’s Primary Supplier for Instrument-Mediated Transfection
                    of Mammalian Cells or Cell Lines by Organization Type
Figure 21: Percentage of Respondents That Have Switched Suppliers in the
                    Last Six Months
Figure 22: Most Important Features of Transfection Products
Figure 23: Respondent’s Primary Application for Mammalian Cells or Cell Lines
                    After Chemically-Mediated Transfection
Figure 24: Respondent’s Primary and Secondary Applications for Mammalian
                    Cells or Cell Lines After Chemically-Mediated Transfection
Figure 25: Respondent’s Primary Application for Mammalian Cells or Cell Lines
                    After Lipid-Mediated Transfection
Figure 26: Respondent’s Primary and Secondary Applications for Mammalian
                    Cells or Cell Lines After Lipid-Mediated Transfection
Figure 27: Respondent’s Primary Applications for Mammalian Cells or Cell
                    Lines After Instrument-Mediated Transfection
Figure 28: Respondent’s Primary and Secondary Applications for Mammalian
                    Cells or Cell Lines After Instrument-Mediated Transfection

Table 1: Frequency of Performance of Various Molecular Biology Techniques
Table 2: Frequency of Co-Performance of Various Molecular Biology Techniques
Table 3: Frequency of Performance of Various Transfection Methods
Table 4: Frequency of Co-Performance of Molecular Biology Techniques with
                Transfection Methods
Table 5: Frequency of Co-Performance of Transfection Methods with Molecular
                Biology Techniques
Table 6: Median and Average Monthly Throughput for Transfection Methods
Table 7: Percentage of Respondents Performing Various Numbers of Reactions
                Per Month by Various Transfection Methods
Table 8: Projected Growth in the Performance of Various Methods for
                Transfection of Mammalian Cells and Cell Lines
Table 9: Median and Average Price Per Prep for Transfection Products
Table 10: Market Share Leaders for Transfection Products
Table 11: Percentage of Respondents Satisfied with Transfection Methods and
                  Reasons for Dissatisfaction

Site Map | Privacy Policy | © 2005-2008 Percepta Associates Inc.